NURECA vs TARSONS: Stock Comparison

Nureca Limited vs Tarsons Products Limited

Live data: 27 July 2026, 4:08 PM IST • Source: NSE and company filings

Tarsons Products Limited is the larger company by market capitalisation. Nureca Limited shows a lower P/E, faster revenue growth and lower leverage, while Tarsons Products Limited shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Nureca Limited and Tarsons Products Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, NURECA is more favourable on 6 of 13 scored metrics and TARSONS on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
TARSONS is the larger company
₹1,717 Cr vs ₹301 Cr
P/E Ratio
NURECA has a lower P/E
108.46x vs 119.22x
P/B Ratio
NURECA has a lower P/B
1.25x vs 2.69x
EPS
TARSONS has higher earnings per share
₹2.7 vs ₹2.1
Revenue Growth (TTM YoY)
NURECA has faster revenue growth
11.5% vs 7.3%
EPS Growth (TTM YoY)
NURECA has faster EPS growth
0% vs -58.9%
Qtr Sales Growth
NURECA has stronger quarterly sales growth
11.6% vs 7.31%
Qtr Profit Growth
TARSONS has stronger quarterly profit growth
-60.6% vs -347%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNURECATARSONS
SectorHealthcareHealthcare
IndustryMedical Equipment & SuppliesMedical Equipment & Supplies

Price

MetricNURECATARSONS
Live Price₹315.7₹320.9
Day Change4.66%2.61%
Volume41,7382.09 L
52-Week High₹343₹382.1
52-Week Low₹204₹164.45
Distance from 52W High-7.96%-16.02%

Valuation

MetricNURECATARSONS
Market Cap₹301 Cr₹1,717 Cr
P/E Ratio108.46x119.22x
P/B Ratio1.25x2.69x
EPS₹2.1₹2.7
Book Value₹191.38₹119.92
Dividend Yield0%0%

Growth

MetricNURECATARSONS
Revenue Growth (TTM YoY)11.5%7.3%
EPS Growth (TTM YoY)0%-58.9%
Qtr Sales Growth11.6%7.31%
Qtr Profit Growth-347%-60.6%

Profitability & Leverage

MetricNURECATARSONS
ROE1.11%2.27%
ROCE3.28%4.56%
Net Margin0.65%3.39%
Operating Margin0.12%5.06%
Debt to Equity0.01x61.91x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNURECATARSONS
Promoter Holding68.09%47.3%
FII Holding0.11% 0.17 pp0.16% 0.71 pp
DII Holding0.24%0.1% 0.09 pp
Public Holding31.57% 0.18 pp52.44% 0.8 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Nureca Limited and Tarsons Products Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.